NO20085308L - Dualmolekyler inneholdende et peroksidderivat, deres syntese og deres terapautiske anvendelser - Google Patents

Dualmolekyler inneholdende et peroksidderivat, deres syntese og deres terapautiske anvendelser

Info

Publication number
NO20085308L
NO20085308L NO20085308A NO20085308A NO20085308L NO 20085308 L NO20085308 L NO 20085308L NO 20085308 A NO20085308 A NO 20085308A NO 20085308 A NO20085308 A NO 20085308A NO 20085308 L NO20085308 L NO 20085308L
Authority
NO
Norway
Prior art keywords
group
cycloalkyl
iia
mixtures
hydrogen atom
Prior art date
Application number
NO20085308A
Other languages
English (en)
Inventor
Bernard Meunier
Frederic Cosledan
Alain Pellet
Original Assignee
Palumed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37719816&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20085308(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Palumed filed Critical Palumed
Publication of NO20085308L publication Critical patent/NO20085308L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Det beskrives dualmolekyler med formel (I) der: A er en molekylær rest med antimalariaaktivitet, med formel (Ila) eller (Illa), eller en rest som letter biotilgjengelighet; B er en cykloalkylgruppe som eventuelt er substituert, eller B representerer en bi- eller tricyklisk gruppe som kan substitueres, eller B representerer 2 cykloalkylgrupper bundet sammen via enten en enkeltbinding eller en alkylenkjede; m og n uavhengig av hverandre er 0, 1 eller 2; R5 er et hydrogenatom, en alkyl-, cykloalkyl- eller C1-3-alkylen-cykloakylgruppe; Z1 og Z2 er en alkylrest, gruppen Z1 + Z2 + Ci + Cj representerer en mono- eller polycyklisk struktur, der en av Z1 eller Z2 er i stand til å representere en enkeltbinding; R1 og R2 er like eller forskjellige og er et hydrogenatom eller en funksjonell gruppe i stand til å øke vannoppløseligheten; Rx og Ry sammen danner et cyklisk peroksid med 4 til 8 bindinger og som inkluderer et eller to ytterligere oksygenatomer i den cykliske struktur, eventuelt substituert med en eller flere R3 grupper; som en base eller som et salt for addisjon til en syre, som et hydrat eller solvat, i racemisk form, samt isomerer og deres blandinger, i tillegg til deres diastereoisomerer og blandinger derav. Det beskrives videre fremstillingsmetoder og anvendelse som medikamenter med antimalariaaktivitet.
NO20085308A 2006-06-13 2008-12-18 Dualmolekyler inneholdende et peroksidderivat, deres syntese og deres terapautiske anvendelser NO20085308L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0605235A FR2902100A1 (fr) 2006-06-13 2006-06-13 Molecules duales contenant un derive peroxydique, leur synthese et leurs applications en therapeutique
PCT/FR2007/000946 WO2007144487A2 (fr) 2006-06-13 2007-06-08 Molecules duales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques

Publications (1)

Publication Number Publication Date
NO20085308L true NO20085308L (no) 2009-03-12

Family

ID=37719816

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20085308A NO20085308L (no) 2006-06-13 2008-12-18 Dualmolekyler inneholdende et peroksidderivat, deres syntese og deres terapautiske anvendelser

Country Status (24)

Country Link
US (1) US20120122923A1 (no)
EP (1) EP2032561A2 (no)
JP (1) JP2009539946A (no)
KR (1) KR20090029208A (no)
CN (1) CN101466706A (no)
AP (1) AP2008004711A0 (no)
AR (1) AR061347A1 (no)
AU (1) AU2007259116A1 (no)
BR (1) BRPI0713739A2 (no)
CA (1) CA2665940A1 (no)
CR (1) CR10469A (no)
EA (1) EA200970002A1 (no)
EC (1) ECSP088958A (no)
FR (1) FR2902100A1 (no)
IL (1) IL195394A0 (no)
MA (1) MA30577B1 (no)
MX (1) MX2008015980A (no)
NO (1) NO20085308L (no)
PE (1) PE20080335A1 (no)
TN (1) TNSN08462A1 (no)
TW (1) TW200817376A (no)
UY (1) UY30413A1 (no)
WO (1) WO2007144487A2 (no)
ZA (1) ZA200810012B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2924343A1 (fr) * 2007-12-04 2009-06-05 Palumed Sa Nouvelles utilisations therapeutiques de molecules duales contenant un derive peroxydique.
JP6026441B2 (ja) 2011-03-04 2016-11-16 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited キナーゼ阻害剤としてのアミノキノリン
TWI547494B (zh) 2011-08-18 2016-09-01 葛蘭素史克智慧財產發展有限公司 作為激酶抑制劑之胺基喹唑啉類
TW201425307A (zh) 2012-09-13 2014-07-01 Glaxosmithkline Llc 作為激酶抑制劑之胺基-喹啉類
AR092529A1 (es) 2012-09-13 2015-04-22 Glaxosmithkline Llc Compuesto de aminoquinazolina, composicion farmaceutica que lo comprende y uso de dicho compuesto para la preparacion de un medicamento
EP2958911B1 (en) 2013-02-21 2017-10-18 GlaxoSmithKline Intellectual Property Development Limited Quinazolines as kinase inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2133620A1 (en) * 1993-10-28 1995-04-29 Werner Hofheinz Aminoquinoline derivatives
WO1997018193A1 (en) * 1995-11-16 1997-05-22 F. Hoffmann-La Roche Ag Antimalarial quinolin derivatives
PL343680A1 (en) * 1998-04-29 2001-08-27 Smithkline Beecham Plc Quinolones used as mrs inhibitors and bactericides
FR2807433B1 (fr) * 2000-04-06 2002-09-20 Centre Nat Rech Scient Molecules duales contenant un derives peroxydique, leur synthese et leurs applications therapeutiques
US6486199B1 (en) * 2001-06-21 2002-11-26 Medicines For Malaria Venture Mmv International Centre Cointrin Spiro and dispiro 1,2,4-trioxolane antimalarials
WO2003070244A1 (en) * 2002-02-22 2003-08-28 Abbott Laboratories Antagonist of melanin concentrating hormone and their uses
SE0202134D0 (sv) * 2002-07-08 2002-07-08 Astrazeneca Ab Therapeutic agents
US20050256157A1 (en) * 2002-08-23 2005-11-17 Chiron Corporation Combination therapy with CHK1 inhibitors
EP1539754A4 (en) * 2002-08-23 2009-02-25 Novartis Vaccines & Diagnostic BENZIMIDAZOLE QUINOLINONES AND USES THEREOF
EP1464335A3 (en) * 2003-03-31 2007-05-09 Taisho Pharmaceutical Co. Ltd. Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist
HU227684B1 (en) * 2003-08-29 2011-11-28 Sanofi Aventis Adamantane and azabicyclo-octane and nonane derivatives and their use as dpp-iv inhibitors
FR2862304A1 (fr) * 2003-11-14 2005-05-20 Centre Nat Rech Scient Molecules duales racemiques ou achirales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques
EP1706384A1 (en) * 2004-01-07 2006-10-04 AstraZeneca AB Therapeutic agents i
JP5128940B2 (ja) * 2004-06-18 2013-01-23 スリーエム イノベイティブ プロパティズ カンパニー 置換イミダゾキノリン、イミダゾピリジン、およびイミダゾナフチリジン
FR2889525A1 (fr) * 2005-08-04 2007-02-09 Palumed Sa Nouveaux derives de polyquinoleines et leur utilisation therapeutique.

Also Published As

Publication number Publication date
EP2032561A2 (fr) 2009-03-11
AP2008004711A0 (en) 2008-12-31
TW200817376A (en) 2008-04-16
UY30413A1 (es) 2008-01-31
WO2007144487A2 (fr) 2007-12-21
AR061347A1 (es) 2008-08-20
US20120122923A1 (en) 2012-05-17
IL195394A0 (en) 2009-08-03
BRPI0713739A2 (pt) 2013-06-18
KR20090029208A (ko) 2009-03-20
MX2008015980A (es) 2009-03-26
CA2665940A1 (fr) 2007-12-21
JP2009539946A (ja) 2009-11-19
TNSN08462A1 (en) 2010-04-14
WO2007144487A3 (fr) 2008-02-07
AU2007259116A8 (en) 2009-04-30
FR2902100A1 (fr) 2007-12-14
MA30577B1 (fr) 2009-07-01
PE20080335A1 (es) 2008-05-22
AU2007259116A1 (en) 2007-12-21
EA200970002A1 (ru) 2009-06-30
CR10469A (es) 2009-02-26
CN101466706A (zh) 2009-06-24
ECSP088958A (es) 2009-01-30
ZA200810012B (en) 2010-05-26

Similar Documents

Publication Publication Date Title
NO20085308L (no) Dualmolekyler inneholdende et peroksidderivat, deres syntese og deres terapautiske anvendelser
NO20076006L (no) Acetylenderivater
CO5721006A2 (es) Derivados de pirazolo-quinazolina, proceso para su preparacion y su uso como inhibidores de quinasa
MX2010003445A (es) Derivados de nicotinamida, su preparacion y su uso terapeutico.
ECSP088253A (es) Derivados de azol y tiazol y sus usos
NO20083520L (no) Tricykliske N-heteroaryl-karboksamidderivater inneholdende en benzimidazolenhet, fremgangsmate for fremstilling av samme og deres terapeutiske anvendelser
NO20055688L (no) Organiske forbindelser
PE20080318A1 (es) Derivados de diceto-piperazina y piperidina como agentes antivirales
CL2009000127A1 (es) Compuestos derivados de [indol, azaindol]-2-carboxamida sustituidos con un grupo silanilo; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y su uso en el tratamiento del dolor, inflamacion, trastornos metabolicos, entre otras enfermedades mediadas por la modulacion del receptor trpv1.
WO2008115098A3 (fr) 2,3,4,5-tétrahydro-1h-pyrido[4,3-b]indoles substitués ainsi que procédés de leur fabrication et leur utilisation
PE20070491A1 (es) Compuestos derivados de 9-azabiciclo[3.3.1]nonano como inhibidores de la recaptacion de neurotransmisores de monoamina
AU2006325931A8 (en) Amine compound and use thereof for medical purposes
WO2004089366A8 (en) Bicyclic compounds as nr2b receptor antagonists
DE602008001725D1 (de) 1-(1-benzylpiperidin-4-yl)benzimidazol-5-carbonsäurederivate zur behandlung von diabetes mellitus
WO2010089510A3 (fr) Dérivés d'azaspiranyl-alkylcarbamates d'hétérocycles à 5 chaînons, leur préparation et leur application en thérapeutique
TW200624432A (en) Imidazo [1,2-a] pyridine compounds, compositions, uses and methods related thereto
MX2010002662A (es) Aminoquinolonas espirociclicas como inhibidores de gsk-3.
AR087302A1 (es) Derivados aza heterociclicos sustituidos
TW200800962A (en) Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
HUP0400682A2 (hu) 5-Hidroxitriptamin-6-ligandumként használható heterociklilalkilindol- és -azaindol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
TW200740795A (en) Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
NO20054092L (no) Nye tricykliske azepinforbindelser, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
AR071619A1 (es) Compuestos de pirazina fusionados utiles para el tratamiento de enfermedades degenerativas e inflamatorias y composiciones farmaceuticas que los contienen.
TW200616679A (en) Modified-release preparation
EA201170899A1 (ru) Производные 2-пиридин-2-ил-пиразол-3(2h)-она, их получение и применение в терапии в качестве активаторов hif

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application